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Purpose: Sarcoidosis is a systemic inflammatory disease characterized by the formation of non-caseating granulomas,
with varied clinical manifestations. The common etiology of sarcoidosis is uncertain, but it is thought to be triggered by
an  exogenous  antigenic  stimulus,  such  as  some  bacterial  proteins.  Toll-like  receptors  (TLRs)  recognize  microbial
components and elicit innate as well as adaptive immune responses. It has been reported that polymorphisms in TLR2
might be important in a small group of Caucasian sarcoidosis patients. The present study aimed to establish whether these
findings are relevant to the Japanese population.
Methods: We genotyped 5 single-nucleotide polymorphisms (SNPs) in TLR2 and assessed the allelic diversity between
257 Japanese sarcoidosis patients and 193 Japanese healthy controls.
Results: No significant differences in the frequency of TLR2 alleles and haplotypes in the sarcoidosis cases were found
in comparison with the controls. However, marginal associations were observed for TLR2 at rs3804099 and rs3804100
in sarcoidosis patients with cutaneous manifestations.
Conclusions: Our results suggest that TLR2 polymorphisms are not significantly related to the pathogenesis of sarcoidosis
in the Japanese population.
Sarcoidosis is a systemic inflammatory disorder resulting
in non-caseating granulomas in multiple organs, such as: lung,
skin,  eye,  lymph  nodes,  central  and  peripheral  nervous
system,  and  heart  [1-3].  Japanese  patients  have  a  higher
likelihood of ocular involvement compared with other ethnic
groups [4]. Ocular manifestation is one of the most common
presentation  in  Japanese  sarcoidosis  patients  [5].
Granulomatous inflammation can occur in any layer of the
eyeball,  and  leads  to  wide  variety  of  ocular  pathology,
including uveitis. A survey of almost 3,000 Japanese patients
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diagnosed with uveitis found that sarcoidosis was the most
frequent (13.3%) cause of non-idiopathic uveitis [6].
The exact cause of sarcoidosis is unknown, but the fact
that the frequency and course of the disease varies widely
among racial groups suggests that genetic factors may be the
basis of disease susceptibility. African Americans are more
commonly  and  severely  affected  by  sarcoidosis  than
Caucasian Americans. The annual sarcoidosis incidence for
African  Americans  is  threefold  higher,  compared  with
Caucasian Americans; at 35.5 versus 10.9 cases per 100,000,
respectively [7]. In the Swedish, another ethnic group, the
annual incidence of sarcoidosis is also high [8]. In Japan, the
annual estimated prevalence is 1.01 per 100,000 [5]. In Korea,
the reported incidence rate is similarly low [9].
Environmental factors are also thought to contribute to
the  disease  progression.  The  DNA  of  Mycobacterium
tuberculosis and Propionibacterium acnes has been detected
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731in some sarcoid lesions by using polymerase-chain-reaction
(PCR) methods [10-13]. Recent studies have also shown that
the serum of some sarcoidosis patients contains antibodies
against mycobacterial antigens [14]. These studies suggest
that  bacterial  infections  can  affect  the  development  of
sarcoidosis.
Toll-like  receptors  (TLRs)  recognize  microbial
components and elicit innate as well as adaptive immune
responses.  Stimulation  with  TLR  ligands  induces  the
production  of  proinflammatory  cytokines  and  type  I
interferons  in  cells  of  the  innate  immune  system  through
intracellular signaling cascades [15-17]. Accumulating data
suggest that TLR polymorphisms are closely associated with
many autoimmune diseases [18-20]. Among the TLR family
members, TLR2 recognizes multiple components of several
bacterial cell walls, including peptidoglycans and lipoproteins
from the cell wall of several bacteria and mycoplasma, by
forming a heterodimer with either TLR1 or TLR6, and plays
a critical role in the activation of innate immunity [21,22].
Polymorphisms  in  TLR2  are  associated  with  impaired
responses to bacterial infection in human [23-27]. Recently,
Veltkamp  et  al.  [28]  reported  that  they  found  the  single
nucleotide  polymorphisms  (SNPs)  located  in  the  TLR2
promoter lesion (rs4696480) was associated with sarcoidosis
in a Dutch Caucasian population, but could not confirm this
in their validation cohort. They inferred from these findings
that a TLR2 variant could play a role in a small percentage of
patients. The association between TLR2 polymorphisms and
sarcoidosis  needs  to  be  confirmed  by  further  replication
studies, particularly in other ethnic groups. In the present
study, we therefore evaluated the association of multiple SNPs
in TLR2 in Japanese patients.
METHODS
Subjects: Two hundred fifty-seven unrelated patients with a
diagnosis  of  sarcoidosis  and  193  healthy  controls  were
recruited  from  Yokohama  City  University,  Hokkaido
University, Fujita Health University, Tokyo University, Keio
University, and Kumamoto City hospital. All patients and
control participants were of Japanese ethnicity. Sarcoidosis
patients were diagnosed according to the diagnostic criteria
developed by the Japanese Society of Sarcoidosis and Other
Granulomatous  Disorders  (JSSOG)  previously  described
[29].  Uveitis  with  sarcoidosis  was  assessed  based  on  the
“Guidelines for Diagnosis of Ocular Lesions in Sarcoidosis”
prepared by the JSSOG. The ocular features of sarcoidosis
were defined as granulomatous uveitis plus two or more of the
following: infiltration of the anterior chamber (mutton-fat
keratic  precipitates/iris  nodules),  trabecular  meshwork
nodules  and/or  tent-shaped  peripheral  anterior  synechia,
masses of vitreous opacities (snowball-like or string of pearls-
like  appearance),  periphlebitis  with  perivascular  nodules;
multiple candle-wax type chorioretinal exudates and nodules,
and/or laser photocoagulation spot-like chorioretinal atrophy.
All subjects had a similar social background and resided in
the  same  urban  area.  The  research  methods  were  in
compliance with the guidelines of the Declaration of Helsinki.
Details of the study were explained to all patients and controls,
and valid consent for genetic screening was obtained.
Analysis  of  TLR2  polymorphisms:  Peripheral  blood
lymphocytes were collected, and genomic DNA was extracted
from peripheral blood cells using the QIAamp DNA Blood
Maxi Kit (Qiagen, Tokyo, Japan). We evaluated five single-
nucleotide polymorphisms (SNPs): rs1898830, rs11938228,
rs3804099, re3804100, and rs7656411 (Figure 1 and Table 1).
These SNPs had minor allele frequencies (>5%) from the
National  Center  for  Biotechnology  Information  db  SNP.
Genotyping of all SNPs was performed using the TaqMan 5′
exonuclease  assay  using  primers  supplied  by  Applied
Biosystems  (Foster  City,  CA).  Probe  fluorescence  signals
were detected by TaqMan Assay for real-time PCR (7500 Real
Time  PCR  System;  Applied  Biosystems)  following  the
manufacturer’s instructions.
Statistical analysis: Hardy–Weinberg equilibrium was tested
for each SNP among the controls. Differences in allele and
genotype  frequencies  between  cases  and  controls  were
assessed by the χ2 test. The Haploview 3.32 (Daly Lab at the
Broad  Institute,  Cambridge,  MA)  program  was  used  to
compute  pair-wise  linkage  disequilibrium  (LD)  statistics
[30]. Standardized disequilibrium (D’) value was plotted, and
LD  blocks  were  defined  according  to  the  criteria  [31].
Haplotype frequencies were estimated using an accelerated
expectation-maximization algorithm similar to the partition-
ligation-expectation-  maximization  method  [32].  P  values
<0.05  were  considered  statistically  significant.  The
Bonferroni method was used to correct multiple comparisons.
RESULTS
We  genotyped  five  common  SNPs  in  the  TLR2  gene:
rs1898830,  rs11938228,  rs3804099,  re3804100,  and
rs7656411 (Figure 1 and Table 1). All five SNPs were in
Hardy–Weinberg  equilibrium  in  the  controls  (data  not
shown). The minor allele frequencies of all SNPs were over
5% in the control group (Table 1). In this study, we did not
examine the polymorphism of rs4696480, because there were
no data for this minor allele in the Japanese HapMap database.
Linkage  disequilibrium  (LD)  blocks  of  five  SNPs  in
TLR2 were defined (Figure 1). The TLR2 region was divided
into two haplotype blocks, with substantial LD among the
SNPs of both blocks (block 1: D’≧1.00; block 2: D’≧0.98).
The allele frequencies of the five SNPs in both the cases and
controls are listed in Table 1, and genotype frequencies are
listed in Table 2. No statistically significant association was
observed for any of the SNPs between the cases and controls
(p>0.05).  We  analyzed  clinical  features  according  to  five
SNPs. In a stratified analysis according to lesion location,
which included the eye, lungs, heart, and nerves, none of these
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732clinical features were found to be significantly associated with
five SNPs (Table 3). Meanwhile, in 51 patients who had
dermatitis,  the  minor  allele  frequencies  of  rs3804099  and
Figure  1.  Linkage  disequilibrium plot  of  five  SNPs  of  TLR2  in
sarcoidosis  patients  and  healthy  controls.  The  schematic  of  the
TLR2 gene is shown as a black line, with boxes representing its three
exons. The locations of the selected SNPs are indicated by the dotted
lines. The Haplotype blocks were determined using the Haploview
4.2 software. Each box provides estimated statistics of the coefficient
of determination, with brighter red representing a stronger Linkage
disequilibrium. Values in squares represent pairwise D’ values.
rs3804100 were higher when compared with the frequency in
193 controls (p=0.021; p=0.013). However, these statistical
differences disappeared after the Bonferroni correction was
applied (p>0.05).
DISCUSSION
The current study was designed to determine whether TLR2
polymorphisms affect the development of sarcoidosis in the
Japanese population. Our results showed that all the TLR2
polymorphisms  so  far  examined  were  not  significantly
associated with any clinical subtype of sarcoidosis including
ocular involvement in the Japanese population. However, a
marginally significant p-value was observed for the SNPs
rs3804099  and  rs3804100  in  patients  with  cutaneous
manifestations, in comparison with the healthy control group.
Healthy  normal  human  skin  contains  two  distinct  major
subsets of resident dendritic cells: Langerhans cells (LCs) and
dermal DCs (DDCs). These DCs are located in the outer skin
layers of the epidermis and play a critical role as the first line
of defense against pathogens invading the skin. These DCs in
the skin, especially DDCs, express TLR2 as well as TLR1 and
TLR6.  DDCs  recognize  bacteria  and  trigger  the  innate
immune response [33]. Our results indicate that a possible
connection may exist between TLR2 polymorphisms and skin
manifestations of sarcoidosis. The variants of the TLR2 gene
in DDCs may play a causative role in the development of
cutaneous sarcoidosis in a site-specific manner.
Several reports have suggested that genetic variants of
innate immune receptors might be associated with the risk of
developing  sarcoidosis  [34].  Innate  immune  dysfunction
caused by genetic factors may fail to eliminate pathogens.
Consequently, it is postulated that frequent stimulation could
lead to the chronic inflammation of sarcoidosis.
TLR4 is a major receptor for lipopolysaccharide (LPS),
a component of gram-negative bacterial cell walls. TLR4 and
TLR2  signal  transduction  results  in  the  activation  of
inflammatory  pathways  involving  nuclear  factor-kappa  B
(NF-kB). Conflicting reports about the association between
TABLE 1. ALLELE FREQUENCIES OF SNPS OF TLR2 AMONG SARCOIDOSIS PATIENTS AND CONTROLS.
        Minor allele frequency,
                 n (%)
   
dbSNP Alleles
(1/2)
Position (bp) Gene
location
Cases
(n=257)
Controls
(n=193)
OR p value
rs1898830 A/G 154,827,903 Intron 232 (45.1) 185 (47.9) 0.89 0.41
rs11938228 C/A 154,841,396 Intron 228 (44.4) 180 (46.6) 0.91 0.50
rs3804099 T/C 154,844,106 Exon 165 (32.1) 108 (28.0) 1.22 0.18
rs3804100 T/C 154,844,859 Exon 155 (30.2) 97 (25.1) 1.29 0.097
rs7656411 G/T 154,847,105 3′UTR 218 (42.4) 168 (43.5) 0.96 0.74
         In the “Alleles” column, 1 indicates the major allele and 2 indicates the minor allele. The position reflects the distance from
         short-arm telomere. p-values were caluculated by χ2 test 2×2 contingency table. bp, base pairs. OR, odds ratio.
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shown that there is a significant association between patients
with  chronic  sarcoidosis  and  TLR4  polymorphisms  in  the
Caucasian  population  [35].  Whereas,  subsequent
investigations  by  other  groups  found  no  significant
association  between  polymorphisms  and  increased
susceptibility to sarcoidosis [36,37]. Our group also could not
find  any  association  between  TLR4  polymorphisms  and
sarcoidosis in the Japanese population [29].
Nucleotide-binding oligomerization domain 2 (NOD2),
a  member  of  the  NLR  (Nod-like  receptor)  family,  is  an
intracellular microbial sensor. This protein detects muramyl
dipeptide (MDP); a component of bacterial peptidoglycans,
and induces innate immune responses. Several reports have
suggested there may be an association of polymorphisms in
NOD2  with  early-onset  sarcoidosis  and  Blau  syndrome.
However,  no  significant  associations  between  the  genetic
polymorphisms  in  the  NOD2  gene  and  the  risk  of  adult
sarcoidosis were detected [36,38-41].
In the present study, genetic variations in TLR2 did not
affect ocular sarcoidosis risk. However, some types of genetic
predispositions underlying the pathogenesis of sarcoidosis
can lead to ocular inflammation. Microbial pathogens have
long been suspected as the cause of sarcoidosis. Therefore,
further studies are needed to analyze other genes involved in
the innate immune response against bacterial antigens.
In summary, the minor allele frequencies of TLR2 do not
appear  to  be  significantly  relevant  to  sarcoidosis  in  the
Japanese  population.  However,  in  cutaneous  sarcoidosis,
rs3804099  and  rs3804100  SNPs  in  TLR2  are  slightly
associated with clinical disease. Further studies, especially in
other  ethnic  populations,  are  required  to  elucidate  what
association there may be between sarcoidosis and TLR2.
TABLE 2. GENOTYPE FREQUENCIES OF FIVE SNPS OF THE TLR2 GENE IN SARCOIDOSIS PATIENTS AND CONTROLS.
SNP Genotype Cases, n (%) Controls, n (%) p value
rs1898830 AA 77 (30.0) 53 (27.5) 0.69
  AG 128 (49.8) 95 (49.2)  
  GG 52 (20.2) 45 (23.3)  
rs11938228 CC 79 (30.7) 56 (29.0) 0.76
  CA 128 (49.8) 94 (48.7)  
  AA 50 (19.5) 43 (22.3)  
rs3804099 TT 116 (45.1) 99 (51.3) 0.39
  TC 117 (45.5) 80 (41.5)  
  CC 24 (9.3) 14 (7.3)  
rs3804100 TT 123 (47.9) 107 (55.4) 0.24
  TC 113 (44.0) 75 (38.9)  
  CC 21 (8.2) 11 (5.7)  
rs7656411 GG 86 (33.5) 62 (32.1) 0.95
  GT 124 (48.2) 94 (48.7)  
  TT 47 (18.3) 37 (19.2)  
           p values were calculated using the χ2 test 3×2 contingency table.
TABLE 3. TLR2 SNPS ALLELE FREQUENCIES AMONG SARCOIDOSIS PATIENTS INFLAMMATORY SITES AND CONTROLS.
  Minor allele frequency, n (%)
      Patients
SNP Alleles
(1/2)
Controls
(n=193)
Cases
(n=257)
Eye
(n=211)
Lungs
(n=138)
Skin (n=51) Heart
(n=49)
Nerve
(n=12)
rs1898830 A/G 185 (47.9) 232 (45.1) 189 (44.8) 131 (47.5) 40 (39.2) 44 (44.9) 11 (45.8)
rs11938228 C/A 180 (46.6) 228 (44.4) 186 (44.1) 128 (46.4) 38 (37.3) 43 (43.9) 11 (45.8)
rs3804099 T/C 108 (28.0) 165 (32.1) 141 (33.4) 91 (33.0) 41 (40.2)* 30 (30.6) 8 (33.3)
rs3804100 T/C 97 (25.1) 155 (30.2) 134 (31.8) 84 (30.4) 39 (38.2)** 27 (27.6) 7 (29.2)
rs7656411 G/T 168 (43.5) 218 (42.4) 170 (40.3) 113 (40.9) 37 (36.3) 43 (43.9) 8 (33.3)
         In the “Alleles” column, 1 indicates the major allele and 2 indicates the minor allele. *p=0.021, Pc>0.05 **p=0.013, Pc>0.06
         These values are not significant after Bonferroni correction.
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